HK1107000A1 - A method for the prevention of thromboembolic disorders - Google Patents

A method for the prevention of thromboembolic disorders

Info

Publication number
HK1107000A1
HK1107000A1 HK07112472.5A HK07112472A HK1107000A1 HK 1107000 A1 HK1107000 A1 HK 1107000A1 HK 07112472 A HK07112472 A HK 07112472A HK 1107000 A1 HK1107000 A1 HK 1107000A1
Authority
HK
Hong Kong
Prior art keywords
prevention
thromboembolic disorders
thromboembolic
disorders
Prior art date
Application number
HK07112472.5A
Other languages
English (en)
Inventor
Heimo Haikala
Jouko Levijoki
Piero Pollesello
Carola Tilgmann
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32338383&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1107000(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corp filed Critical Orion Corp
Publication of HK1107000A1 publication Critical patent/HK1107000A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK07112472.5A 2004-05-12 2007-11-15 A method for the prevention of thromboembolic disorders HK1107000A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20040674A FI20040674A0 (fi) 2004-05-12 2004-05-12 Menetelmä tromboembolisten sairauksien estoon
PCT/FI2005/000220 WO2005107757A2 (en) 2004-05-12 2005-05-12 A method for the prevention of thromboembolic disorders

Publications (1)

Publication Number Publication Date
HK1107000A1 true HK1107000A1 (en) 2008-03-28

Family

ID=32338383

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07112472.5A HK1107000A1 (en) 2004-05-12 2007-11-15 A method for the prevention of thromboembolic disorders

Country Status (16)

Country Link
US (2) US8017609B2 (es)
EP (1) EP1744752A2 (es)
JP (1) JP5074923B2 (es)
KR (1) KR20080020930A (es)
CN (1) CN1980673B (es)
AR (1) AR050903A1 (es)
AU (1) AU2005239847B2 (es)
CA (1) CA2564033A1 (es)
EA (1) EA010890B1 (es)
FI (1) FI20040674A0 (es)
HK (1) HK1107000A1 (es)
NO (1) NO20065669L (es)
NZ (3) NZ579537A (es)
TW (1) TWI366463B (es)
WO (1) WO2005107757A2 (es)
ZA (1) ZA200609304B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20040674A0 (fi) * 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
WO2006087420A2 (en) * 2005-02-18 2006-08-24 Orion Corporation A method for treating heart failure
JP2010514778A (ja) * 2006-12-28 2010-05-06 オリオン コーポレーション 非経口投与のためのレボシメンダン製剤
TW200920371A (en) 2007-08-29 2009-05-16 Orion Corp A combination treatment
WO2010097501A2 (en) * 2009-02-26 2010-09-02 Orion Corporation A combination treatment
WO2011027021A1 (en) 2009-09-01 2011-03-10 Orion Corporation A method for the treatment of hypertension
EP2322163A1 (en) * 2009-11-03 2011-05-18 Pharnext New therapeutics approaches for treating alzheimer disease
KR101910153B1 (ko) * 2016-11-04 2018-10-19 한국과학기술연구원 타우 관련 질환의 예방 또는 치료용 레보시멘단 화합물
WO2019216589A1 (ko) * 2018-05-09 2019-11-14 한국과학기술연구원 타우 관련 질환의 예방 또는 치료용 조성물
CA3161960A1 (en) 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hfpef)
CN115518037A (zh) * 2022-10-14 2022-12-27 上药东英(江苏)药业有限公司 一种安全质量稳定的左西孟旦注射剂组合物及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1468111A (en) * 1976-01-08 1977-03-23 Pfizer Ltd Thiophene-sulphonamides
DE3209159A1 (de) * 1982-03-13 1983-09-15 Basf Ag, 6700 Ludwigshafen Neue 6-aryl-4,5-dihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung, diese verbindungen enthaltende therapeutische mittel und deren verwendung
JPS63141970A (ja) * 1986-12-04 1988-06-14 Morishita Seiyaku Kk 4,5−ジヒドロ−6−(4−置換フエニル)−3(2h)−ピリダジノン誘導体
GB2251615B (en) 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US5945432A (en) * 1995-12-22 1999-08-31 The University Of Vermont And State Agricultural College Thrombolytic agents and thienopyridine derivatives in acute stroke
EP1008348A4 (en) * 1997-02-27 2001-04-04 Ajinomoto Kk THROMBOLYTIC AGENT
FI974578A (fi) * 1997-12-19 1999-06-20 Orion Yhtymae Oyj Menetelmä levosimendaanin antamiseksi
US5905078A (en) 1998-06-19 1999-05-18 Orion Corporation Use of a pyridazinone derivative
FI20001542A (fi) * 2000-06-29 2001-12-30 Orion Yhtymae Oyj Menetelmä septisen sokin hoitamiseksi
FI20011464A0 (fi) * 2001-07-04 2001-07-04 Orion Corp Yhdistelmäterapia sydämen vajaatoiminnan hoitoon
FI20011465A0 (fi) 2001-07-04 2001-07-04 Orion Corp Pyridatsinonijohdannaisen uusi käyttö
PT1430045E (pt) * 2001-09-21 2007-01-31 Novartis Ag Derivados de pirano como inibidores de ace e nep
FI20020197A0 (fi) 2002-02-01 2002-02-01 Orion Corp Yhdistelmä akuutin myokardiilisen infarktin hoitoon
FI20030015A0 (fi) * 2003-01-03 2003-01-03 Orion Corp Menetelmä munuaisten vajaatoiminnan hoitamiseksi
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
FI20040674A0 (fi) * 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
CN101031302A (zh) * 2004-05-28 2007-09-05 艾博特公司 用于治疗心脏停搏前、期间和之后的哺乳动物的方法
WO2006087420A2 (en) * 2005-02-18 2006-08-24 Orion Corporation A method for treating heart failure
DK1951227T3 (en) 2005-11-14 2017-07-10 Boehringer Ingelheim Vetmedica Gmbh APPLICATION OF PIMOBENDAN TO TREAT ASYMPTOMATIC (OCCULT) HEART FAILURE

Also Published As

Publication number Publication date
JP2007537209A (ja) 2007-12-20
FI20040674A0 (fi) 2004-05-12
EA010890B1 (ru) 2008-12-30
CA2564033A1 (en) 2005-11-17
EA200602096A1 (ru) 2007-04-27
NO20065669L (no) 2006-12-08
ZA200609304B (en) 2008-01-30
WO2005107757A3 (en) 2006-01-19
AU2005239847B2 (en) 2010-08-26
US8017609B2 (en) 2011-09-13
JP5074923B2 (ja) 2012-11-14
CN1980673B (zh) 2011-11-23
US20110301166A1 (en) 2011-12-08
AU2005239847A1 (en) 2005-11-17
TWI366463B (en) 2012-06-21
NZ550814A (en) 2009-10-30
CN1980673A (zh) 2007-06-13
US20080039467A1 (en) 2008-02-14
KR20080020930A (ko) 2008-03-06
TW200536546A (en) 2005-11-16
EP1744752A2 (en) 2007-01-24
NZ579536A (en) 2011-03-31
WO2005107757A2 (en) 2005-11-17
AR050903A1 (es) 2006-12-06
NZ579537A (en) 2010-05-28
US8329693B2 (en) 2012-12-11

Similar Documents

Publication Publication Date Title
HK1107000A1 (en) A method for the prevention of thromboembolic disorders
HK1107821A1 (en) Method for the production of dihydropteridinones
TWI367259B (en) A method for the detection of chromosomal aneuploidies
PT2479680T (pt) Método para apresentação de streams de velocidade de transmissão adaptável
HK1109239A1 (zh) 維護方法
IL176767A0 (en) Production method
IL188923A0 (en) Method for predicting the response to a treatment
EP1951084A4 (en) TOOTHBRUSH DEVICE AND METHOD OF MANUFACTURING THEREOF
IL191619A0 (en) Method for purifying fsh or a fsh mutant
ZA200803268B (en) Plants having increased yield and a method for making the same
IL184655A0 (en) Plants having increased yield and a method for making the same
IL180893A0 (en) Method for the preparation of a d-erythro-2,2-difluoro-2-deoxy-1-oxoribose derivative
PL1794111T3 (pl) Sposób wytwarzania cyklopentanonu
GB2445531B (en) A melt transurethane process for the preparation of polyurethanes
HUE036153T2 (hu) Eljárás poliizocianátok elõállítására
GB2430940B (en) A component forming method
EP1907377A4 (en) PROCESS FOR THE PREPARATION OF ALMOTRIPTANE
GB0422378D0 (en) A method
GB0407125D0 (en) A process
GB0407120D0 (en) A process
GB0407124D0 (en) A process
GB0407123D0 (en) A process
TJ16Y3 (en) A method for total vestibuboplastic of the top jawat adentia
ZA200700282B (en) Method for the production of dihydropteridinones
GB0505898D0 (en) Improved method for the manufacture of a building product

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150512